Ultragenyx Pharmaceutical Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Debt-to-equity for the quarter ending September 30, 2024 was 398 %, a 38.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 398 -249 -38.5% Sep 30, 2024
Q2 2024 543 +142 +35.5% Jun 30, 2024
Q1 2024 828 +587 +243% Mar 31, 2024
Q4 2023 726 +570 +367% Dec 31, 2023
Q3 2023 647 +543 +522% Sep 30, 2023
Q2 2023 400 +329 +460% Jun 30, 2023
Q1 2023 241 +178 +284% Mar 31, 2023
Q4 2022 156 +98.1 +170% Dec 31, 2022
Q3 2022 104 +49.5 +91% Sep 30, 2022
Q2 2022 71.5 +12 +20.1% Jun 30, 2022
Q1 2022 62.9 -3.48 -5.25% Mar 31, 2022
Q4 2021 57.5 -20.8 -26.6% Dec 31, 2021
Q3 2021 54.4 -34.2 -38.6% Sep 30, 2021
Q2 2021 59.5 -10.3 -14.8% Jun 30, 2021
Q1 2021 66.4 +16.6 +33.4% Mar 31, 2021
Q4 2020 78.4 +49.4 +171% Dec 31, 2020
Q3 2020 88.6 +71.4 +415% Sep 30, 2020
Q2 2020 69.9 +54 +340% Jun 30, 2020
Q1 2020 49.7 +34.5 +226% Mar 31, 2020
Q4 2019 29 +13.8 +91.2% Dec 31, 2019
Q3 2019 17.2 +0.81 +4.94% Sep 30, 2019
Q2 2019 15.9 -1.22 -7.13% Jun 30, 2019
Q1 2019 15.2 -2.56 -14.4% Mar 31, 2019
Q4 2018 15.2 -2.98 -16.4% Dec 31, 2018
Q3 2018 16.4 +1.51 +10.1% Sep 30, 2018
Q2 2018 17.1 +3.51 +25.8% Jun 30, 2018
Q1 2018 17.8 +5.91 +49.7% Mar 31, 2018
Q4 2017 18.1 +7.49 +70.4% Dec 31, 2017
Q3 2017 14.9 +6.54 +78.4% Sep 30, 2017
Q2 2017 13.6 +7.42 +120% Jun 30, 2017
Q1 2017 11.9 +6.05 +104% Mar 31, 2017
Q4 2016 10.6 +5.42 +104% Dec 31, 2016
Q3 2016 8.34 +2.94 +54.4% Sep 30, 2016
Q2 2016 6.18 +0.15 +2.48% Jun 30, 2016
Q1 2016 5.84 +0.28 +5.04% Mar 31, 2016
Q4 2015 5.22 -0.63 -10.8% Dec 31, 2015
Q3 2015 5.4 -3.09 -36.4% Sep 30, 2015
Q2 2015 6.04 Jun 30, 2015
Q1 2015 5.56 Mar 31, 2015
Q4 2014 5.85 Dec 31, 2014
Q3 2014 8.49 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.